Literature DB >> 26484430

Use of Daptomycin in Critically Ill Children With Bloodstream Infections and Complicated Skin and Soft-tissue Infections.

Sara Tedeschi1, Fabio Tumietto, Matteo Conti, Maddalena Giannella, Pierluigi Viale.   

Abstract

We report our clinical experience with the use of daptomycin, administered in the dosage of 8 mg/kg/d in 3 minutes, in treating 12 critically ill children younger than 12 years, with bloodstream infections (n = 9) and complicated skin and soft-tissue infections (n = 3). Mean treatment duration was 14 ± 5 days; microbiologic eradication was achieved in all patients, and no drug related adverse events occurred.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26484430     DOI: 10.1097/INF.0000000000000962

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  2 in total

1.  Community-Acquired MRSA Pericarditis and Mediastinitis in a Previously Healthy Infant.

Authors:  Joselito Sanchez; Amanda Schneider; Justin T Tretter; Bo Shopsin; Yasir Al-Qaqaa; Alka Khaitan; Tanya Chadha
Journal:  J Pediatr Intensive Care       Date:  2017-10-26

2.  Dosing Recommendations for Pediatric Patients With Renal Impairment.

Authors:  Amer Al-Khouja; Kyunghun Park; Daijha J C Anderson; Caitlyn Young; Jian Wang; Shiew Mei Huang; Mona Khurana; Gilbert J Burckart
Journal:  J Clin Pharmacol       Date:  2020-06-15       Impact factor: 3.126

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.